Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $1.4 million.

  • Onconetix's Shares Outstanding (Weighted Average) rose 904661.59% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 904661.59%. This contributed to the annual value of $2.7 million for FY2024, which is 54181.08% up from last year.
  • Per Onconetix's latest filing, its Shares Outstanding (Weighted Average) stood at $1.4 million for Q3 2025, which was up 904661.59% from $567648.0 recorded in Q2 2025.
  • Onconetix's Shares Outstanding (Weighted Average)'s 5-year high stood at $18.2 million during Q1 2025, with a 5-year trough of $6528.0 in Q2 2024.
  • For the 3-year period, Onconetix's Shares Outstanding (Weighted Average) averaged around $5.1 million, with its median value being $567648.0 (2025).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first tumbled by 9995.9% in 2024, then soared by 904661.59% in 2025.
  • Quarter analysis of 3 years shows Onconetix's Shares Outstanding (Weighted Average) stood at $427784.0 in 2023, then skyrocketed by 541.81% to $2.7 million in 2024, then plummeted by 48.81% to $1.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.4 million for Q3 2025, versus $567648.0 for Q2 2025 and $18.2 million for Q1 2025.